Efficacy and Safety of PRO-148 Versus Systane®, in Patients With Mild to Moderate Dry Eye

NCT01657253 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

183

Enrollment

INDUSTRY

Sponsor class

Conditions

Dry Eye

Interventions

DRUG: PRO-148
DRUG: Systane

Sponsor

Laboratorios Sophia S.A de C.V.